Acne Treatments
Active acne is not one disease. It is a family of lesion patterns and drivers, each on its own treatment ladder. This hub places you in the right type and routes you to the right plan.
Five acne types — pick the one that matches your pattern
Acne breaks down into five recognisable patterns at clinic. The cards below describe what each pattern looks like and where it routes for treatment. Most adult-women patients overlap two patterns — for example inflammatory plus hormonal — and the consultation refines this into an exact plan against your skin, your history, your hormonal context, and your reproductive plans. Patterns are graded against the GAGS score photographically; this is what determines whether the plan is topical-led, antibiotic-paired, hormonal-evaluated, or isotretinoin-evaluated.
Comedonal acne
Blackheads and whiteheads dominate; little or no inflammation. Treated with topicals; antibiotics not needed.
- Lots of blackheads or whiteheads
- Few inflamed pimples
- Pores look congested
Inflammatory acne
Red papules and pustules dominate. Treatment combines topicals with short oral antibiotic courses where appropriate.
- Red painful pimples
- Pus-tipped lesions
- New flares each week
Cystic / nodulocystic acne
Deep painful nodules and fluid-filled cysts. Severe by definition; isotretinoin candidacy assessed early to prevent scarring.
- Large painful lumps below the surface
- Lesions that take weeks to settle
- New scars forming on photographs
Hormonal acne
Cyclic flares before menstruation, lower-face/chin/jawline distribution, often in adult women. Hormonal pathway evaluated alongside topicals.
- Acne flares before period
- Lower-face / jaw distribution
- PCOS or hormonal context
Adult-onset acne
Acne starting or persisting in your 20s, 30s, or 40s. Drivers and treatment differ from teenage acne and need adult-specific assessment.
- Acne first started after 20
- Acne persisting into 30s and beyond
- Different from teenage pattern
Not sure which type — pick the closest sentence
If you would describe your acne in one of the phrases below, the chip routes you to the page that matches. The "I am unsure" route lands at consultation.
Seven treatment routes used inside active acne
Each row covers one treatment route used at DDC. The mix of routes used for any one patient depends on type, severity, prior history, and reproductive plans.
Topical regimens
Retinoids (adapalene, tretinoin), benzoyl peroxide, topical antibiotics paired with BPO — first-line for comedonal and inflammatory acne.
Oral antibiotics
Doxycycline or lymecycline, capped at 8–12 weeks, always paired with topicals for stewardship.
Hormonal therapy
Combined OCPs with anti-androgenic progestins or spironolactone for adult women with cyclic lower-face flares and hormonal drivers.
Oral isotretinoin
Most evidence-supported pathway for severe nodulocystic acne; full candidacy assessment, baseline workup, and contraception protocol.
Intralesional triamcinolone
Single small steroid injection for an acute painful cyst before an event — adjunct, not a routine treatment.
Peels for acne
Salicylic and mandelic peel courses — adjunct for comedonal and mixed acne, calibrated for Indian skin.
Maintenance after clearance
Low-frequency topical retinoid plus barrier-supportive routine — reduces relapse risk after a successful course.
Featured pages — treatment-led and guide-led
The first group is the deep treatment pages. The second group is patient-friendly guides for the most-asked patterns. Use the treatment pages once you know your type; use the guides if you want orientation first.
Treatment-led pages
These T1 pages cover the full treatment ladder for active acne, from topical-only plans through to systemic therapy.
Patient guides — by acne type
Plain-language guides for the most common acne patterns. Use them when you want depth on a single type rather than the full treatment ladder.
Active acne guide
Educational walkthrough of inflammatory acne — what it is and how it is treated.
Open pageHormonal acne guide
PCOS and cyclic-flare patterns explained for adult women.
Open pageTeenage acne guide
Patient-friendly explainer for the teenage pattern and why it needs early care.
Open pageAdult acne guide
Adult-onset and persistent-adult acne — drivers and treatment differences.
Open pageCystic acne guide
Educational guide on severe nodulocystic disease.
Open pageActive-acne concerns — grouped by clinical family
The cluster cards group active-acne concerns by severity, lesion type, driver, recovery stage, and decision-aid. Use them to find the cluster that matches your pattern.
By severity grade
GAGS-graded acne — mild, moderate, severe, very severe — drives treatment intensity.
By lesion type
Comedonal, inflammatory, nodulocystic — each pattern shapes the first-line plan.
By driver
Hormonal, steroid-induced, occlusion-driven — drivers change the plan more than lesion appearance does.
Recovery — once acne is settled
Once active acne is controlled, the recovery phase opens up — marks, scars, texture, maintenance.
Comparison and decision-aids
Side-by-side resources for choosing between in-clinic care and at-home routines.
Treatment approaches — grouped by method
Same content as the concern clusters, indexed by treatment approach. Useful if you arrive thinking about a specific method (topical, oral, hormonal, isotretinoin, adjunct). The right method for your acne depends on type, severity, prior history, and reproductive plans — the consultation maps these factors against your specific case rather than applying a default protocol.
First-line topical regimen
Retinoid + BPO is the backbone for comedonal and inflammatory acne; antibiotics added selectively.
Oral antibiotics — selective and short
Capped at 8–12 weeks, always with BPO and topical retinoid; never indefinite monotherapy.
Hormonal pathway
Combined OCPs and spironolactone for adult women with hormonal drivers; co-managed where indicated.
Isotretinoin pathway
Severe / refractory acne — full candidacy assessment, baseline workup, contraception protocol, monthly monitoring.
Adjuncts and maintenance
Peels, intralesional steroid for acute cysts, and topical retinoid maintenance after clearance.
Right type, right plan — written down before treatment begins
Acne treatment goes wrong most often when type is misread or driver is missed. The four operating commitments below are how DDC keeps the plan honest from the first visit.
-
Type-led routing
The plan is matched to your specific acne type and severity — not a generic "acne treatment" packaged the same way for every patient.
-
Antibiotic stewardship
Oral antibiotics are short-course, paired with topicals, and never repeated reflexively. Stewardship reduces resistance and protects future options.
-
Hormonal context
Adult women with cyclic lower-face flares are evaluated on the hormonal pathway alongside topical care, not on topicals alone.
-
Scar prevention urgency
For severe nodulocystic disease, escalation is faster — scar prevention is the clinical objective, not just lesion clearance.
Indian Skin Safety — calibrated to acne type and skin tone
Treatment intensity in active acne sits inside a higher pigment-risk envelope on Fitzpatrick III–V skin. Calibration is the difference between clean clearance and a long pigment recovery.
Type-aware dosing
Topical retinoid concentration starts lower for darker skin and titrates up; benzoyl peroxide is paired with barrier-supportive moisturiser; oral antibiotics are short-course with sun protection counselling.
Driver-aware planning
Hormonal patterns are evaluated alongside topicals — not on topicals alone — because relapse without addressing the driver is the most common reason adult-female acne recurs.
Procedure-aware sequencing
Peels and lasers run gentler in Indian skin: mandelic preferred over high-strength glycolic during active disease, low-fluence laser only after stabilisation, and any device avoided altogether during a flare.
Doctor logic and first-visit experience
The decision method below shows how the dermatologist routes you to the right treatment within active acne. The second list shows what actually happens at the first visit.
Decision method — six structured steps
Type
Comedonal, inflammatory, cystic, hormonal, adult-onset, teenage, or body — sometimes mixed.
Severity
GAGS scoring across face, chest, and back; presence of nodules and active scarring.
Driver
Hormonal pattern, steroid-cream history, pregnancy plans, occupational triggers.
History
Prior topicals, antibiotics, isotretinoin, OCPs — what worked, what failed, and why.
Plan
Written treatment ladder with timeline, indicative cost, and side-effect briefing.
Review
Photograph-led review every 4–6 weeks; escalation logic documented.
First visit — six things that happen
Type assessment
Lesion-type count and distribution across face, chest, and back; Fitzpatrick assessment.
Photographs
Standardised baseline photographs for objective tracking through the course.
History
Medications, products, prior treatments, hormonal pattern in adult women, steroid-cream use.
Investigations
Hormonal screen for adult women with cyclic flares; baseline workup if isotretinoin is on the table.
Plan
Written, scoped to your type and timeline, with realistic 8–12-week or 4–6-month targets.
Home-care
Cleanser, moisturiser, sunscreen, and prescribed actives — calibrated to your skin and type.
What not to do in active acne
The patterns below are the most common reasons active-acne treatment goes wrong. Stopping any of them now is itself a treatment.
- Do not take repeated antibiotic courses without escalation.
Antibiotic courses beyond 12 weeks, repeated reflexively without addressing topical regimen or hormonal driver, breed resistance and reduce future options. The pattern of relapse points to a missing diagnosis, not a missing antibiotic.
- Do not use steroid or fairness creams on the face.
Topical steroid mixtures cause steroid-induced rosacea-like acne, dilated vessels, and recurrent pustules. Stopping abruptly causes a severe rebound flare; supervised tapering is essential.
- Do not start isotretinoin from a friend or chemist.
Isotretinoin needs baseline blood work, contraception protocol for women of reproductive age, signed consent, and monthly monitoring. Self-prescribed courses skip the safety scaffolding that makes the medication safe.
- Do not blindly choose a peel or facial during active disease.
Aggressive peels and high-fluence lasers on inflamed Indian skin produce pigment damage that outlasts the original acne. Modality choice belongs at the consultation, not at a salon counter.
- Do not expect a fixed all-inclusive package.
Active acne plans price differently for topical-only, antibiotic-paired, hormonal, and isotretinoin pathways. A plan with indicative ranges in writing is the right form of cost certainty.
What honest improvement looks like by acne type
Active-acne improvement timelines differ across types. Each type below has its own response window, escalation logic, and maintenance pattern. This framing replaces the generic "how long does treatment take" answer with the type-specific reality.
Comedonal and mild inflammatory
Most adherent patients see meaningful improvement within 8–12 weeks of a topical retinoid and benzoyl peroxide regimen. Antibiotics are not first-line in this band. Maintenance is a low-frequency retinoid 2–3 nights per week, indefinitely. Patients who stop the maintenance retinoid the moment skin clears are the ones who most reliably return with relapse months later.
Inflammatory and moderate
A combination regimen with topical retinoid, benzoyl peroxide, and a short oral antibiotic course (8–12 weeks, never indefinite) produces meaningful response in 10–16 weeks for most adherent patients. Antibiotic stewardship is enforced — the antibiotic is paired with a topical from day one, never repeated reflexively, and never extended past 12 weeks without escalation. Hormonal evaluation enters the discussion for adult women with cyclic flares.
Severe nodulocystic — isotretinoin window
Severe nodulocystic disease with active scar formation is evaluated for isotretinoin candidacy at the first or second visit. The course typically runs 4–6 months at 0.5–1.0 mg/kg/day, targeting a cumulative dose around 120–150 mg/kg. Around 70–80 % of patients remain clear for years after a complete course; relapse rates are documented honestly, and re-treatment is a reasonable evidence-supported option in a smaller subset. Pregnancy is an absolute contraindication; the contraception protocol is mandatory throughout.
Where this hub sits — parent and sibling hubs
The Acne Treatments Hub branches off the Skin Hub. The Acne and Acne Scars Hub is the umbrella above this hub; the Acne Scar Treatments and Pigmentation hubs sit alongside for the recovery phase.
Skin Hub (parent)
Top-level skin gateway — acne is one of seven skin pathways.
Open hub Hub · F043Acne and Acne Scars Hub
Phase-led umbrella spanning active acne, marks, scars, and texture.
Open hub Hub · F045Acne Scar Treatments Hub
Structural-scar pathways — sequenced after acne is stable.
Open hub Hub · F046Pigmentation Hub
Pigment patterns including post-acne hyperpigmentation.
Open hubWhat you can verify — and where to read further
The signals below are what we hold ourselves to and what you can independently check. Below them sit four patient-facing guides and comparisons that go deeper on a single type or decision.
Active acne guide
Patient-friendly explainer of inflammatory acne and treatment expectations.
ReadHormonal acne guide
How hormonal patterns shape adult-female acne and what is evaluated.
ReadCystic acne guide
Severe nodulocystic disease explained — and why it is treated as urgent.
ReadClinic vs home
When at-home routines suffice and when in-clinic care is the right escalation.
ReadPlace your acne in the right type — book a consultation
The next step is not picking a topical from a list. It is identifying the type, the driver, and the right treatment ladder, written down with realistic targets. That happens at the consultation.
This page is medical education for patients. It is not a diagnosis, it is not a prescription, and it does not promise an outcome. Recurrence is part of acne biology.
Starting from ₹1,999*. Final cost is explained in writing at the consultation.
Frequently asked questions
Eight questions cover the most common confusions about active-acne treatment selection — type-vs-type framing, antibiotic stewardship, isotretinoin appropriateness, hormonal context, teenage versus adult patterns, realistic timelines, hub differentiation against the umbrella hub above, and how cost actually works at DDC. Each answer stands alone; none of them substitutes for the consultation, which is where the plan that applies to your specific skin and history gets written down.
Which acne treatment is right for me?
It depends on your acne type, severity, prior treatment history, hormonal context, and skin type. Comedonal acne usually needs only topicals; inflammatory acne often combines topicals with a short oral-antibiotic course; severe cystic acne is evaluated for isotretinoin; adult-female cyclic-flare patterns add a hormonal pathway. The consultation places you in the right type and writes the plan in writing.
Do I need oral antibiotics for acne?
Not always. Oral antibiotics are reserved for moderate inflammatory acne and used short-course (8–12 weeks) with topical retinoid and benzoyl peroxide as paired agents. Antibiotic monotherapy and indefinite courses breed resistance and reduce future options. If a clinician offers long repeated antibiotic courses without escalation, that is below the standard of acne stewardship.
When is isotretinoin appropriate?
Isotretinoin is the most evidence-supported pathway for severe nodulocystic acne, for active scar formation regardless of severity, and for acne refractory to an adherent combination regimen. It is started after baseline blood work, contraception counselling for women of reproductive age, and signed consent. Pregnancy is an absolute contraindication. Detail sits on the cystic-acne page; this hub orients you to whether isotretinoin should be on the table.
Is hormonal acne treated differently in adult women?
Yes. The lower-face / chin / jawline distribution and cyclic premenstrual flare pattern characteristic of adult-female hormonal acne respond best to a hormonal pathway alongside topicals — combined OCPs with anti-androgenic progestins or spironolactone in selected cases. Topical-and-antibiotic regimens treat the inflammation but not the driver, and relapse is common if the hormonal context is not addressed.
Can teenage acne be left to settle on its own?
Mild teenage acne sometimes settles, but moderate or severe teenage acne loaded with deep inflammatory lesions tends to scar if untreated. Early dermatology assessment prevents scarring; once scars form they are permanent without procedural treatment. Treating teenage acne early is a scar-prevention decision, not a cosmetic one.
How long does acne treatment take?
Most mild-to-moderate plans need 8–12 weeks before fair judgement. Severe or cystic plans need 4–6 months of active treatment, sometimes longer. Maintenance continues after clearance to reduce relapse. Compressing this timeline rarely helps and frequently triggers irritation, barrier damage, or post-inflammatory pigmentation that needs separate care.
What is the difference between this hub and the Acne and Acne Scars Hub?
The Acne and Acne Scars Hub is the umbrella that covers the full lifecycle (active, marks, scars, texture). This hub focuses specifically on treatment selection within active acne — by type, severity, and driver. If you are unsure of phase, the umbrella hub is the right starting point; if you know you are in active treatment and want type-led routing, this hub is the next step.
How much does acne treatment cost at DDC?
Consultation starts from ₹1,999*. Beyond consultation, cost depends on the plan — topical-only, supervised oral antibiotic course, hormonal pathway with co-management, or a full isotretinoin course with monthly reviews and serial blood work. Each option is priced differently. The consultation produces a transparent indicative range in writing; there are no fixed all-inclusive packages.
Last reviewed April 2026 by Dr Chetna Ghura, MBBS MD Dermatology, DMC 2851. Next review due April 2027. Medical education only — not a diagnosis or prescription. Treatment decisions are made only after clinical assessment.